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Curcumin is a plant secondarymetabolitewith outstanding therapeutic effects.
Therefore, there is a great interest in developing new strategies to produce this
high-value compound in a cheaper and environmentally friendly way. Curcu-
min heterologous production in Escherichia coli using artificial biosynthetic
pathways was previously demonstrated using synthetic biology approaches.
However, the culturing conditions to produce this compound were not opti-
mized and so far only a two-step fermentation process involving the exchange
of culture medium allowed high concentrations of curcumin to be obtained,
which limits its production at an industrial scale. In this study, the culturing con-
ditions to produce curcumin were evaluated and optimized. In addition, it was
concluded that E. coli BL21 allows higher concentrations of curcumin to be pro-
duced than E. coli K-12 strains. Different isopropyl b-D-thiogalactopyranoside
concentrations, timeofprotein expression induction andsubstrate type and con-
centration were also evaluated. The highest curcumin production obtainedwas
959.3 mM (95.93% of per cent yield), whichwas 3.1-fold higher than the highest
concentration previously reported. This concentration was obtained using a
two-stage fermentation with lysogeny broth (LB) and M9. Moreover, terrific
brothwas also demonstrated to be avery interesting alternativemedium to pro-
duce curcumin because it also led to high concentrations (817.7 mM). The use of
this single fermentation medium represents an advantage at industrial scale
and, although the final production is lower than that obtained with the LB–
M9 combination, it leads to a significantly higher production of curcumin in
the first 24 h of fermentation. This study allowed obtaining the highest concen-
trations of curcumin reported so far in a heterologous organismand is of interest
for all of those working with the heterologous production of curcuminoids,
other complex polyphenolic compounds or plant secondary metabolites.
1. Introduction
Curcumin is a polyphenol found in the plant Curcuma longa and is well known
for its several therapeutic benefits. It exhibits excellent anti-cancer potential [1,2]
and has also been shown to have anti-inflammatory [3], antidiabetic [4] and
anti-Alzheimer’s [5] properties, among others. Despite its innumerous thera-
peutic applications curcumin has extremely low aqueous solubility, chemical
stability and poor bioavailability, which has limited its clinical use [1,2]. Curcu-
min is mainly obtained using costly, energy-intensive and environmentally
unfriendly extraction processes [6]. The yields obtained are low because it
accumulates in low amounts over long growth periods in plants. In addition,
its chemical synthesis is complex [7]. All these reasons make its heterologous
biosynthetic production very interesting [6].
Recently, curcumin and other curcuminoids were produced in Escherichia
coli using combinatorial biosynthesis [6,8–13]. Curcumin can be produced by
feeding amino acids or ferulic acid (figure 1). The short pathway from ferulic
acid uses two or three enzymes: 4-coumarate-CoA ligase (4CL) from different
plants, diketide-CoA synthase (DCS) and curcumin synthase (CURS1) from
C. longa [8] or curcuminoid synthase (CUS) from Oryza sativa [10]. CUS
catalyses both steps that are catalysed separately by DCS and CURS1.
ferulic acid
feruloyl-CoA
feruloyl-diketide-CoA
feruloyl-CoA
curcumin
CURS1
CURS1
b-keto acid
DCSmalonyl-CoA
4CL
Figure 1. Curcumin biosynthetic pathway in E. coli using ferulic acid as sub-
strate. 4CL, 4-coumarate-CoA ligase; DCS, diketide-CoA synthase; CURS,
curcumin synthase.
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produced by heterologous hosts using two separate cultiva-
tion steps [8,10,12]. Usually the strains are first grown in
lysogeny broth (LB) to produce large amounts of biomass
and reach a suitable protein production level. After reaching
the exponential phase, the cells are harvested and transferred
to M9 modified minimal salt medium, where the substrates
(amino acids or ferulic acid) are added and the curcuminoids
are produced. There are also some reports of other curcumi-
noids produced in LB supplemented with glucose after
protein expression [11,14]. Although the two-step fermenta-
tion strategy is feasible at the laboratory scale, the
separation of biomass is much more difficult, laborious and
expensive in large-scale fermentations. Therefore, it is very
important to optimize the fermentation conditions, including
media and operating parameters. In this study, we describe
the production of curcumin from ferulic acid in different
E. coli strains carrying a biosynthetic pathway previously
described by our group [8]. Several fermentation parameters
were studied and it was possible to obtain for the first time
very high concentrations of curcumin using a single
medium. The curcumin concentrations obtained in this
study are the highest reported so far.2. Material and methods
2.1. Bacterial strains and plasmids
Escherichia coli NZY5a competent cells were purchased from
NZYTech (Lisbon, Portugal) and were used for molecularcloning and vector propagation. Escherichia coli K-12 MG1655
(DE3), E. coli K-12 JM109 (DE3) and E. coli BL21 (DE3) were
tested as hosts for the expression of the curcumin biosynthetic
pathway. Table 1 summarizes the characteristics of all strains
and plasmids used. The construction of pCDFDuet_DCS and
pRSFDuet_CURS1 was previously described by our group [8].
The DNA sequences of the codon-optimized genes are provided
in the electronic supplementary material, table S1. pAC-4CL1
plasmid was provided by Claudia Schmidt-Dannert [16] through
Addgene (Cambridge, MA, USA; plasmid 35947). The selected
hosts were transformed with the three plasmids using
electroporation.2.2. Curcumin production
For the production of curcumin, different strains, culture media,
isopropyl b-D-thiogalactopyranoside (IPTG) concentrations and
times of induction were tested (electronic supplementary
material, figure S1).2.2.1. Culture media
LB, agar and super optimal broth with catabolite repression
(SOC) were purchased from NZYTech and were used to prepare
pre-inoculums and in the transformations. LB was also used as
the production medium. In addition to LB, M9 modified minimal
salt medium, MOPS (morpholinepropanesulfonic acid) minimal
medium and TB (terrific broth) were used:
— M9 modified minimal salt medium contained (per litre): 40 g
glucose (Acros, Geel, Belgium), 6 g Na2HPO4 (Scharlau,
Sentmenat, Spain), 3 g KH2PO4 (Riel-deHae¨n, Seelze,
Germany), 1 g NH4Cl, 0.5 g NaCl, 15 mg CaCl2 (Panreac,
Barcelona, Spain), 110 mg MgSO4 (Riel-deHae¨n), 340 mg
thiamine (Fisher Scientific, Loughborough, UK) and 5 g
CaCO3 (Panreac) (to control the pH). Trace elements
(54 mg FeCl3, 4 mg ZnCl2, 4 mg CoCl2, 2 mg CuCl2
(Riedel-deHae¨n), 4 mg NaMoO4 and 1 mg H2BO3 (Merck,
Kenilworth, NJ, USA)) and vitamins (0.84 mg riboflavin,
10.8 mg pantothenic acid (Sigma-Aldrich, Steinheim,
Germany), 2.8 mg pyridoxine, 0.084 mg folic acid, 0.12 mg
biotin (Merck) and 12.2 mg nicotinic acid (Riedel-deHae¨n))
were added to the medium.
— MOPS minimal medium contained (per litre): 40 g glucose,
10 ml of 0.132 M K2HPO4 and 100 ml of 10 MOPS mixture.
The 10 MOPS mixture contained (per litre): 83.72 g MOPS
(Fisher Scientific), 7.17 g tricine (ChemCruz, Dallas, TX,
USA), 0.028 g FeSO4 (Sigma-Aldrich), 50 ml of 1.9 M
NH4Cl, 10 ml of 0.276 M K2SO4 (Panreac), 0.25 ml of 0.02 M
CaCl2.2H2O, 4.2 ml of 1.25 M MgCl2 (VWR, Radnor, PA,
USA), 100 ml of 5 M NaCl, 0.2 ml of micronutrient solution
(containing per 50 ml: 9 mg (NH4)6Mo7O24.4H2O (Fluka,
Buchs, Switzerland), 62 mg H3BO3 (Merck), 18 mg CoCl2,
6 mg CuSO4 (Sigma-Aldrich), 40 mg MnCl2 (Merck) and
7 mg ZnSO4 (Sigma-Aldrich)). Final pH was adjusted to 7.2
with NaOH.
— TB medium contained (per litre): 12 g tryptone (Oxoid,
Basingstoke, UK), 24 g yeast extract (Oxoid), 4 ml of a 10%
(v/v) glycerol solution (HiMedia, Mumbai, India), 9.4 g
K2HPO4 (Panreac) and 2.2 g KH2PO4. In some experiments,
0.4–4% glycerol final concentrations were used (instead of a
0.04% glycerol final concentration) or 40 g l21 glucose was
supplemented to TB.
Spectinomycin (100 mg ml21) (Panreac), chloramphenicol
(30mg ml21), and kanamycin (50 mg ml21) (NZYTech) were
also added to all media. IPTG (NZYTech) was added at a final
concentration of 1 mM unless otherwise stated. Ferulic acid
Table 1. Bacterial strains and plasmids used in this study.
strains relevant genotype source
E. coli NZY5a fhuA2D(argF2lacZ)U169 phoA glnV44 F80 D(lacZ)M15 gyrA96 recA1 relA1
endA1 thi-1 hsdR17
NZYTech (MB00401)
E. coli K-12 MG1655(DE3) F2 l2 ilvG2 rfb250 rph21 l(DE3) [15]
E. coli K-12 JM109(DE3) endA1 recA1 gyrA96 thi hsdR17 (rk
2, mk
þ) relA1 supE44 l2 D(lac-proAB)
[F0 traD36 proAB lacIq D(lacZ)M15] l(DE3)
Promega (P9801)
E. coli BL21(DE3) fhuA2 [lon] ompT gal l(DE3) [dcm] DhsdSB NEB (C2527)
plasmids construct source
pCDFDuet_DCS CloDF13 ori, lacI, double T7lac, StrepR; pCDFDuet-1 carrying codon-optimized
DCS from Curcuma longa
[8]
pRSFDuet_CURS1 RSF ori, lacI, double T7lac, KanR; pRSFDuet-1 carrying codon-optimized CURS1 from C. longa
pAC-4CL1 P15A ori, Plac, CmR, pACYC184-derived plasmid carrying 4CL1 from Arabidopsis thaliana Addgene (35947)
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concentration of 2 mM.
2.2.2. Production conditions
Firstly, curcumin was produced in the three strains (§2.1) using
the combination of LB (for biomass and protein production)
and M9 (for curcumin production) previously tested [8,10]. Cul-
tures were grown at 378C in 50 ml LB in 250 ml flasks to an
optical density at 600 nm (OD600) of 0.4 (for E. coli K-12
MG1655(DE3)) or 0.6–0.7 (for E. coli K-12 JM109(DE3) and E.
coli BL21(DE3)). The protein expression was induced with IPTG
(1 mM) and the culture was then incubated for 5 h at 268C.
Next, the cells were harvested by centrifugation, suspended
and incubated at 268C for 63 h in 50 ml M9 medium in 250 ml
flasks. Ferulic acid (2 mM) and IPTG (1 mM) were added at
time 0 of induction in M9 medium. Both media contained
IPTG at a final concentration of 1 mM.
In the case of E. coli BL21(DE3), the optimal IPTG concen-
tration in LB (0.1 mM, 0.5 mM, 1 mM or 1.5 mM), need for
IPTG in M9 medium (0 mM) and optimal OD600 (0.4–0.9) for
induction of protein expression were also evaluated. Afterwards,
other culture media (§2.2.1) and other combinations of media
were also tested. LB, MOPS and TB were tested for the simul-
taneous biomass/protein and curcumin production. In these
cases, the temperature was also decreased from 378C to 268C
and the substrate was added after 5 h of protein expression. In
parallel, LB or TB were also combined with MOPS. The addition
of the same, but fresh, media 5 h after protein expression/before
adding the substrate was also tested in the case of LB and TB.
Based on the results obtained with TB, different types and con-
centrations of carbon sources at different phases were
evaluated (§2.2.1).
All experiments were conducted in triplicate. Supernatant
samples (1.5 ml) were collected for the analysis of substrate,
while for the analysis of curcumin 500 ml of culture broth with
cells (whole broth) was collected.
2.3. Curcumin extraction
For subsequent curcumin analysis, 500 ml of whole broth was
adjusted to pH 3.0 with 6 M HCl (Fisher Scientific). Then, curcu-
min, which is produced intracellularly, was extracted from the
cells with an equal volume of ethyl acetate (Fisher Scientific).
The extracts were concentrated by solvent evaporation in a
fume hood, suspended with 200 ml of acetonitrile and subjec-
ted to product analysis by ultra-high-performance liquid
chromatography (UHPLC).2.4. Ultra-high-performance liquid chromatography
analysis
UHPLC analysis was used to quantify ferulic acid and curcumin
using the Shimadzu Nexera-X2 (Shimadzu Corporation, Kyoto,
Japan) (CBM-20A system controller, LC-30AD pump unit,
DGU-20A 5R degasser unit, SPD-M20A detector unit, SIL-30AC
autosampler unit, CTO-20ACcolumnoven) systemandaGraceAll-
tech Platinum EPS C18 column (3 mm, 150 mm  4.6 mm) (Grace,
Columbia, MD, USA). Mobile phase A was composed of water
with 0.1% (v/v) of trifluoroacetic acid (Fluka). Mobile phase B was
composed of acetonitrile (Fisher Scientific). For ferulic acid quantifi-
cation, the following gradient was used at a flow rate of 1 ml min21:
10–20%acetonitrile (mobile phase B) for 16 min.Quantificationwas
based on the peak areas at 310 nm for ferulic acid and the retention
timewas9.7 min.Forcurcuminquantification, agradientof 40–43%
acetonitrile (mobile phase B) for 15 min and 43% acetonitrile for an
additional 5 min was used. Curcumin was detected at 425 nm of
absorbance and the retention time was 17.6 min. Curcumin used
to prepare standards was purchased from Fisher Scientific.3. Results and discussion
3.1. Selection of the best host to produce curcumin
The selection of the heterologous host for the production of cur-
cumin is important because, depending on the strain, the
concentrations reached can be very different. Indeed, the pro-
ductions previously obtained in different strains were
significantly different. For example, the highest curcumin con-
centration obtained in our previous work [8] was 187.9 mM
using E. coli K-12 MG1655(DE3), while Katsuyama et al. [10]
were able to obtain306.7 mM using E. coli BLR(DE3). The fer-
mentation conditions used inboth studieswere the samebut the
enzymesusedweredifferent (and/or fromdifferentorganisms).
Therefore, itwasnot possible to concludewhether thedifference
obtained was due to the strain used or, for example, due to the
possibly higher catalytic efficiency of CUS compared with the
combination ofDCS andCURS1. Thus, the production of curcu-
min using the same fermentation conditions and biosynthetic
pathwaywas tested in this study, varying only theE. coli strains.
The productions obtained in three E. coli strains available in our
laboratorywere compared (figure 2).As it is possible to observe,
the production in E. coli BL21 was very high (483.1 mM), 2.72-
fold higher than that produced with E. coli K-12 MG1655
(177.9 mM). E. coli K-12 JM109, a strain widely used for the
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Figure 2. Curcumin production in E. coli K-12 MG1655 (DE3), E. coli K-12
JM109(DE3) and E. coli BL21(DE3). LB (lysogeny broth) was used for cell
growth and protein expression and M9 medium for the curcumin production
phase. The optical density (600 nm) at the moment of induction was 0.4 for
E. coli K-12 MG1655 and 0.6 for E. coli K-12 JM109 and E. coli BL21. Error
bars are standard deviations from triplicate experiments. Two-way ANOVA was
used to determine statistically significant differences and is denoted as fol-
lows: **** indicates p-value , 0.0001 and ** indicates p-value , 0.01.
See the electronic supplementary material, table S2, for more detailed
information regarding statistical significance.
1500
1000
500
cu
rc
u
m
in
 c
on
ce
nt
ra
tio
n 
(µM
)
0
20
n.s.
n.s.
**
****
****
****
****
****
****
****OD = 0.4
OD = 0.6
OD = 0.8
OD = 0.9
43 63
time (h)
Figure 3. Effect of optical density at 600 nm (OD600) at the time of induction
of protein expression in curcumin production in E. coli BL21(DE3). LB (lyso-
geny broth) was used for cell growth and protein expression and M9 medium
for the curcumin production phase. Error bars are standard deviations from
triplicate experiments. Two-way ANOVA was used to determine statistically
significant differences and is denoted as follows: **** indicates p-value ,
0.0001, **indicates p-value , 0.01 and n.s. indicates no significant differ-
ence ( p. 0.05). See the electronic supplementary material, table S3, for
more detailed information regarding statistical significance.
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of recA and endA that have a positive effect on plasmid stability
[15], was also tested but the curcumin production was low
(73.2 mM). E. coli BLR is a BL21-related strain, and they are
both derived from B strains. B strains are excellent for protein
expression because they are deficient in Lon and OmpT pro-
teases, which degrade many heterologous proteins [17–19]. In
addition, the parental strain (B834) that gave rise to BL21 has a
mutation in the hsdSBgenewhichprevents plasmiddegradation
[19,20]. Besides these genetic differences, E. coli B strains have a
more efficient central carbon metabolism, thus they tolerate
higher glucose concentrations, produce less acetate and grow
to higher OD than E. coli K-12 [15,21–24], which can be very
advantageouswhen expressing biosynthetic pathways. Acetate,
which is a growth inhibitor, accumulates less in E. coli BL21
because this strain presents a higher expression of acetyl-CoA
synthetase during the glucose exponential phase [25]. This
enzyme converts acetate to acetyl-CoA, which in turn is con-
verted to malonyl-CoA, whose availability in the cell is very
important for curcumin production [6].
The comparison of these production results also suggests
that our pathway, which consisted of 4CL1 from Arabidopsis
thaliana and DCS and CURS1 from C. longa, is more efficient
than the pathway described by Katsuyama et al. [10], which
consisted of 4CL from Lithospermum erythrorhizon, CUS and
overexpression of acetyl-CoA carboxylase from E. coli.
3.2. Optimization of induction parameters (OD and
IPTG) in Escherichia coli BL21(DE3) when using the
combined LB and M9 medium to produce
curcumin
The OD600 at the time of induction has proved to highly influ-
ence curcumin production when E. coli K-12 MG1655(DE3)was used as host [8]. Therefore, the optimal OD600 to
induce protein expression and produce curcumin was also
evaluated for E. coli BL21. The curcumin production obtained
at different OD600 values for the induction of protein
expression can be observed in figure 3. The addition of
IPTG at an OD600 of 0.9 yielded the highest production titre
(959.3 mM), thus suggesting that induction should be per-
formed at high OD600 values. An early induction can
probably impose a metabolic burden on the host strain
associated with protein overexpression. When the cells are
induced after the exponential phase there is a higher cell den-
sity for product formation. However, after the exponential
phase the metabolic state of the cells may not be favourable
for protein expression because they may be under stressful
conditions and trigger a response that increases protease
levels, which can reduce the yield of heterologous proteins
[26]. Protein induction using E. coli BL21 could be performed
at a later stage than when E. coli K-12 MG1655(DE3) was used
(OD600 ¼ 0.4), probably because E. coli BL21 lacks some pro-
teases and is less sensitive to growth conditions, usually
growing to a higher OD as stated before [15].
The optimal IPTG concentration for protein induction and
consequently substrate conversion was also investigated. In
previous studies, IPTG was added to a final concentration of
1 mM in LB and then in M9 minimal medium. In figure 4, it is
possible to compare the curcumin production for different
IPTG concentrations tested (0.1, 0.5, 1.0 and 1.5 mM). These
concentrations were tested in both LB and M9 medium. In
addition, in one of the tests 1 mM of IPTG was added to LB
and no IPTG was added to the M9 medium. The study of
the best IPTG concentration is important because protein
expression does not respond predictably to IPTG concen-
tration. IPTG is actively transported across the cell
membrane by permeases or permease-independent pathways
[27] and, therefore, the IPTG that enters each cell is highly
variable. As can be seen in figure 4, the highest curcumin pro-
duction (822.6 mM) was obtained when 0.1 mM of IPTG was
added and the increase in the production is statistically
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Figure 4. Effect of IPTG (isopropyl b-D-1-thiogalactopyranoside) concen-
tration in curcumin production by E. coli BL21(DE3). IPTG was added to LB
(lysogeny broth) for protein expression: 0.1, 0.5, 1.0 or 1.5 mM (final con-
centration) and the same correspondent concentrations were added to the
M9 medium. In one of the assays IPTG (1.0 mM) was only added to LB
medium. Protein expression was induced when cells reached an optical den-
sity (OD600nm) of 0.6 unless otherwise stated in the legend. Error bars are
standard deviations from triplicate experiments. Two-way ANOVA was used
to determine statistically significant differences and is denoted as follows:
**** indicates p-value, 0.0001, ** indicates p-value , 0.01, * indicates
0.01 , p-value  0.05 and n.s. indicates no significant difference ( p.
0.05). See the electronic supplementary material, table S4, for more detailed
information regarding statistical significance.
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Figure 5. Curcumin production over time in different culture media in E. coli
BL21(DE3). Curcumin was produced in MOPS (morpholinepropanesulfonic
acid) medium, in LB (lysogeny broth) and TB (terrific broth). In some
cases, different media were used for the two phases (LB-MOPS, TB-MOPS)
or the same medium was used but before the substrate was added the
cells were centrifuged and resuspended in fresh medium (LB–LB, TB–
TB). Protein expression was induced with 1.0 mM IPTG (isopropyl b-D-1-thio-
galactopyranoside) when cells reached an optical density (OD600nm) of 0.6.
Error bars are standard deviations from triplicate experiments. Two-way
ANOVA was used to determine statistically significant differences and is
denoted as follows: **** indicates p-value , 0.0001 and ** indicates
p-value , 0.01. See the electronic supplementary material, table S5, for
more detailed information regarding statistical significance.
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lead to titre enhancement, suggesting that metabolic burden
effects may be affecting productivity [28–30]. High expression
of heterologous proteins can have a negative and unpredict-
able effect on the cell growth while expression levels that
are too low might reduce the encounter frequency between
the enzymes and the substrates [28–31]. Owing to this unpre-
dictability it is important to optimize the IPTG concentration.
The need to add IPTG in the phase of production (in M9
medium) was also evaluated (figure 4, white bar). By compar-
ing the result obtained (589.8 mM) with that where 1 mM of
IPTG was added in both steps (LB and M9 medium)
(524.8 mM), it is possible to conclude that the addition of
IPTG in the production phase may not be needed. This pos-
sibly occurred because in this case the metabolic burden is
reduced.
Finally, we evaluated whether the curcumin concen-
tration could be improved by inducing the cells at an OD
of 0.9, which proved to be favourable (figure 3), and by
adding only 0.1 mM of IPTG. As can be observed in
figure 4, the combination of both optimal parameters did
not significantly increase the production (831.9 mM). The
initial conditions tested, OD of 0.9 and IPTG of 1 mM
(figure 3), proved to be the best conditions to produce
curcumin in this culture medium.3.3. Optimization of culture media to produce curcumin
using Escherichia coli BL21(DE3)
In this study, different cultivation media for the entire pro-
duction bioprocess were evaluated in order to avoidmedium exchange in the middle of the process. This would
make the curcumin production easier, more attractive and
also more economically viable for an industrial scale-up. LB
and M9 medium were previously tested in a one-step cultiva-
tion strategy using E. coli K-12 MG1655(DE3) but it was
concluded that the productions were very low (data not
shown). Therefore, other media such as TB and MOPS were
tested because they were previously used to successfully pro-
duce plant secondary metabolites [32,33]. In addition,
different media combinations (LB-MOPS and TB-MOPS)
and exchange to the same, but fresh, medium (LB–LB and
TB–TB) were also tested with the aim of finding a combi-
nation that allowed higher titres to be obtained. The
productions obtained can be observed in figure 5. TB
medium, from all the new media tested, proved to be the
best one to produce curcumin (535.8 mM at 43 h). In addition,
in this medium it is possible to obtain higher concentrations
of curcumin in the first 24 h than when using the combination
LB–M9, which represents an advantage for industrial-scale
production. The other combinations tested led to low curcu-
min productions. The use of fresh TB medium in the
production phase also allowed significantly higher concen-
trations of curcumin to be obtained but the high content of
the carbon source probably had an inhibitory effect when
compared with the case where the same TB was used in
both phases. TB is a phosphate-buffered rich medium and
has 20% more tryptone and 380% more yeast extract than
LB. In addition, TB also has glycerol as an extra carbon
source. This high nutritive content and the presence of pot-
assium phosphates that prevent a drop in pH of the
medium during bacterial growth allow E. coli to maintain
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Figure 6. Effect of different carbon source concentrations in TB (terrific broth) in curcumin production by E. coli BL21(DE3). All experiments contained 0.04% (v/v)
glycerol at the beginning of the fermentation except TB (glycerol 0.4%), which contained 0.4% glycerol. In the other experiments, glycerol or glucose were
supplemented when the susbtrate was added (5 h after protein expression induction). Protein expression was induced with 1.0 mM IPTG (isopropyl
b-D-1-thiogalactopyranoside) when cells reached an optical density (OD600nm) of 0.6, unless otherwise stated in the legend. Error bars are standard deviations
from triplicate experiments. Two-way ANOVA was used to determine statistically significant differences and is denoted as follows: **** indicates p-value ,
0.0001, *** indicates p-value, 0.001, ** indicates p-value , 0.01, * indicates 0.01 , p-value  0.05 and n.s. indicates no significant difference ( p.
0.05). See the electronic supplementary material, table S6, for more detailed information regarding statistical significance.
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yields of recombinant protein and plasmid DNA [34]. M9
modified minimal medium was also buffered (by the
addition of CaCO3), which was essential to obtain the high
concentrations reported (figures 2–4) in this medium [35,36].3.4. Optimization of carbon source concentration in
terrific broth medium
TB was demonstrated to be an optimal medium for both
stages of curcumin production (figure 5). Therefore, the
effect of induction time in TB medium was evaluated and,
although at an OD600 of 0.8–0.9 the production was higher
than at an OD600 of 0.4 and 0.6 (data not shown), the differ-
ences were not statistically significant ( p. 0.05). In parallel,
different concentrations of glycerol were tested with the goal
of improving the production (figure 6). TB contained 0.04%
(v/v) glycerol at the beginning of the fermentation except in
one case where a 0.4% concentration was tested (figure 6,
TB (glycerol 0.4%)). This concentration was tested as it is the
concentration present in most TB formulations [34]. In this
study, glycerol or glucose were also supplemented when the
substrate was added (5 h after induction with IPTG). As can
be seen in figure 6, the supplementation of glucose had a
negative/inhibitory effect on curcumin production. The pres-
ence of glucose, a preferred carbon source, represses the
synthesis and activity of key proteins for transport and metab-
olism of glycerol [37]. In addition, the supplementation of
glucose is known to enhance acetic acid production, which
reduces the pH of the medium. This acidic shift in a first
phase inhibits protein production and then retards E. coli
growth [38,39]. Glucose accumulation can also promote the
growth of plasmid-free cells [40].
Regarding the different concentrations of glycerol tested,
the best result was obtained when 0.04% glycerol was
added at the beginning of the fermentation and then 1% ofglycerol was added with the substrate (686.7 mM at 43 h).
This experiment was repeated but in the conditions pre-
viously optimized for the LB and M9 combination—the
protein expression was induced at an OD of 0.9 and
0.1 mM or 1.0 mM IPTG was tested. At an OD of 0.9 and
0.1 mM IPTG, it was possible to improve curcumin pro-
duction (817.7 mM at 63 h) by 31% at 63 h. This production
is very high and almost equivalent to the highest one
obtained using the LB and M9 combination (959.3 mM),
which clearly demonstrates that the TB medium should be
considered at industrial scale for the production of curcumin
because it allows the operational process to be simplified and
reduces the operational costs related to the exchange of the
culture medium. In addition, this medium allows a higher
production of curcumin to be obtained in the first 24 h of fer-
mentation than the combination of LB–M9. To further
decrease the costs of the fermentation medium (TB), alterna-
tive low-cost substrates could be considered. For instance,
corn steep liquor could be tested as a nitrogen source because
it is an inexpensive residue compared with the commonly
used sources, namely yeast extract and tryptone. In addition,
crude glycerol arising from biodiesel production could be
evaluated towards the development of a more sustainable
process.4. Conclusion
The optimization of curcumin fermentation conditions is
essential to increase the production and yields of this impor-
tant therapeutic agent. So far, curcumin has only been
produced with high yields in a two-step fermentation that
involves the exchange of fermentation medium, which is
not ideal at an industrial scale. Herein we study different
parameters including different E. coli strains, IPTG concen-
trations, time of protein expression induction and substrate
type and concentration. Escherichia coli BL21(DE3) enabled
rsif.royalsocietypublishing.org
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In the end, we were able not only to increase curcumin pro-
duction from ferulic acid by 3.1-fold, but also to produce it
using a single fermentation medium without any significant
decrease in the production or yield. TB proved to be an opti-
mum culture medium to produce curcumin. The productions
obtained in this study, 817.7 mM (301 mg l21) in TB and
959.3 mM (353 mg l21) in the combined LB and M9
medium, are the highest reported so far, as well as the per
cent yields of 81.8–95.9%. In the future, the potential of
industry by-products and residues could be tested in curcu-
min production aiming at the development of a sustainable
bioprocess based on the circular bioeconomy concept. In
addition, factorial experiment designs can be used to opti-
mize other relevant variables (e.g. duration of protein
expression before substrate addition) before starting the bio-
process scale-up. In bioreactor production, other parameters
will have to be taken into account, such as aeration and agita-
tion rates that may influence cellular growth and,
consequently, curcumin production. Additionally, the avail-
ability of the natural precursor malonyl-CoA can be studiedand further improved by different metabolic engineering
strategies.
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